HIP
PACB icon

HUB Investment Partners’s Pacific Biosciences PACB Stock Holding History

HUB Investment Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.2K Hold
40,000
– – ﹤0.01% 1314
2026
Q1 		$52.8K Buy
+40,000
New +$71.6K ﹤0.01% 1104

Other funds holding PACB

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
KCPG
Kavar Capital Partners Group Leawood, Kansas $812M AUM 29.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HUB Investment Partners's PACB Position: Q2 2026 in Review

HUB Investment Partners increased its Pacific Biosciences (PACB) stake by 12% in Q2 2026, buying an estimated $11.6K and bringing the position to 75,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

HUB Investment Partners first reported a position in PACB in Q2 2025 and has held it in 5 quarters since. 49 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • HUB Investment Partners held 75,000 shares of Pacific Biosciences worth $126K as of Q2 2026.
  • HUB Investment Partners bought 8,000 Pacific Biosciences shares in Q2 2026, an estimated $11.6K.
  • Pacific Biosciences made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1261 holding.
  • HUB Investment Partners first reported a position in Pacific Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 49 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.